Literature DB >> 28467548

Pembrolizumab-Induced Extensive Panniculitis and Nevus Regression: Two Novel Cutaneous Manifestations of the Post-immunotherapy Granulomatous Reactions Spectrum.

Sara Burillo-Martinez1, Carlos Morales-Raya1, Marta Prieto-Barrios1, Jose-Luis Rodriguez-Peralto2, Pablo-Luis Ortiz-Romero1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28467548     DOI： 10.1001/jamadermatol.2017.0581

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  9 in total

Review 1.  Checkpoint Inhibitors.

Authors:  Lucie Heinzerling; Enrico N de Toni; Georg Schett; Gheorghe Hundorfean; Lisa Zimmer
Journal:  Dtsch Arztebl Int       Date:  2019-02-22       Impact factor: 5.594

Review 2.  Sarcoid-like reaction in cases treated by checkpoint inhibitors.

Authors:  Semra Paydas
Journal:  Med Oncol       Date:  2021-02-18       Impact factor: 3.064

3.  Suspected immune checkpoint inhibitor-induced pulmonary sarcoid reaction in metastatic renal cell carcinoma.

Authors:  Victoria Purcell; Beatrice Preti; Ricardo Fernandes
Journal:  Clin Case Rep       Date:  2022-07-11

4.  Sarcoid-like Granulomatosis Associated with Immune Checkpoint Inhibitors in Melanoma.

Authors:  Audrey Melin; Émilie Routier; Séverine Roy; Pauline Pradere; Jerome Le Pavec; Thibaut Pierre; Noémie Chanson; Jean-Yves Scoazec; Olivier Lambotte; Caroline Robert
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

5.  Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients.

Authors:  Michael T Tetzlaff; Kelly C Nelson; Adi Diab; Gregg A Staerkel; Priyadharsini Nagarajan; Carlos A Torres-Cabala; Beth A Chasen; Jennifer A Wargo; Victor G Prieto; Rodabe N Amaria; Jonathan L Curry
Journal:  J Immunother Cancer       Date:  2018-02-12       Impact factor: 13.751

6.  Pembrolizumab-induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient.

Authors:  Anthony D Honigman; Franics Lai; Joshua Elakis; Owen Prall; Michelle Goh; Christopher McCormack
Journal:  Clin Case Rep       Date:  2019-03-11

Review 7.  Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel.

Authors:  Jade Cury-Martins; Adriana Pessoa Mendes Eris; Cristina Martinez Zugaib Abdalla; Giselle de Barros Silva; Veronica Paula Torel de Moura; Jose Antonio Sanches
Journal:  An Bras Dermatol       Date:  2020-02-15       Impact factor: 1.896

Review 8.  Melanoma and Vitiligo: In Good Company.

Authors:  Cristina Maria Failla; Maria Luigia Carbone; Cristina Fortes; Gianluca Pagnanelli; Stefania D'Atri
Journal:  Int J Mol Sci       Date:  2019-11-15       Impact factor: 5.923

9.  Erythema nodosum-like panniculitis associated with immune checkpoint inhibitor therapy: Two cases reporting a rare cutaneous adverse event.

Authors:  Jolanta Pach; Katherine Moody; Nan Ring; Gauri Panse; Michael Zhang; Sandhya Deverapalli; Jonathan Leventhal
Journal:  JAAD Case Rep       Date:  2021-05-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.